Case Study
Strategic PICO Planning: Navigating Oncology Markets with NAVLIN by EVERSANA
In today’s complex and highly competitive healthcare environment, early and strategic PICO (Population, Intervention, Comparator, Outcome) planning is essential for successful evidence generation and market access. Evolving regulatory requirements, including the European Joint Clinical Assessment (JCA), increasingly rely on PICO frameworks to support consistent therapy evaluations across the EU. NAVLIN by EVERSANA® helps organizations anticipate health technology assessment (HTA) requirements, align cross-functional stakeholders, and make informed decisions throughout an asset’s lifecycle. In a case study involving a crowded oncology market, NAVLIN applied its PICO planner methodology to deliver customized and actionable strategies, enabling the client to better address evidence needs, pre
